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Abstract: The Medicines Use Review is a community pharmacy service funded in the United 
Kingdom to improve patients’ adherence to medication and reduce medicines waste. The 
objective was to develop, pilot, and utilize a new Medicines Use Review patient satisfaction 
questionnaire. A questionnaire for patient self-completion was developed using a published 
framework of patient satisfaction with the Medicines Use Review service. The questions were 
validated using the content validity index and the questionnaire piloted through three pharma-
cies (February–April 2016). The revised questionnaire contained 12 questions with responses 
on a 5-point Likert scale, and a comments box. The questionnaire was distributed to patients 
following a Medicines Use Review consultation via community pharmacies (June–October 
2016). Exploratory factor analysis and Cronbach’s α were performed to investigate the relation-
ships between the items and to examine structural validity. The survey results were examined 
for patients’ reported satisfaction with Medicines Use Reviews, while the handwritten com-
ments were thematically analyzed and mapped against the questionnaire items. An estimated 
2,151 questionnaires were handed out, and a total of 505 responses were received indicating a 
24% response rate. Exploratory factor analysis revealed two factors with a cumulative variance of 
68.8%, and Cronbach’s α showed high internal consistency for each factor (α=0.90 and α=0.89, 
respectively). The survey results demonstrated that patients could show a high degree of overall 
satisfaction with the service, even if initially reluctant to take part in a Medicines Use Review. 
The results support the Medicines Use Review patient satisfaction questionnaire as a suitable 
tool for measuring patient satisfaction with the Medicines Use Review service. A wider study 
is needed to confirm the findings about this community pharmacy-based adherence service.
Keywords: community pharmacy, Medicines Use Review, patient satisfaction, questionnaire, 
adherence
Plain language summary
We wanted to see if patients are happy with a drug store service. The service focuses on checking 
people’s medicines with them. The service is also about checking that people are taking their 
medicines. We produced a list of questions for people to answer. We made certain that the list 
of questions was as best as possible. We gave the list of questions to over 2,000 people. Just 
over 500 people sent us their answers. People were happy with the service even if they did not 
want to take part at first. Our results mean we have a list of questions for other people to use 
in the future.
Introduction
The medical management and prevention of many conditions rely on the prescribing 
and use of medicines. Yet, for a variety of reasons, patients commonly fail to adhere 
to medication instructions.1,2 The issue of medication nonadherence is particularly 
correspondence: Parastou Donyai
Department of Pharmacy, harry 
nursten Building, University of reading, 
Whiteknights, PO BOX 226, reading, 
Berkshire, rg6 6AP, UK
email p.donyai@reading.ac.uk 
Journal name: Patient Preference and Adherence
Article Designation: Original Research
Year: 2017
Volume: 11
Running head verso: Hindi et al
Running head recto: MUR patient satisfaction questionnaire
DOI: http://dx.doi.org/10.2147/PPA.S146991
 
Pa
tie
nt
 P
re
fe
re
nc
e 
an
d 
Ad
he
re
nc
e 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
4.
22
5.
10
9.
63
 o
n 
14
-N
ov
-2
01
7
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Patient Preference and Adherence 2017:11submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1798
hindi et al
problematic with chronic conditions where adherence is 
estimated to be around 50%.3 Medication nonadherence 
potentially reduces clinical benefit and quality of life in 
patients, in turn increasing the burden of ill health, medicines 
waste, hospitalization, emergency admissions, and death.4 
As a potential solution, medication adherence reviews are 
offered as a pharmacy service across a number of European 
countries, including the United Kingdom.5
In the UK, the Medicines Use Review (MUR) service con-
sists of a yearly one-to-one patient–pharmacist consultation; 
introduced in 2005, the aim of the service is to address con-
cerns and questions about all of a patient’s medication to 
improve their adherence.6 Yet, patients’ satisfaction with 
the service has not been formally measured. Internation-
ally, the World Health Organization has emphasized the 
importance of the patient’s perspective in the evaluation of 
health services.7 Patient satisfaction is broadly conceptual-
ized as the extent to which a patient is content with a health 
service encounter. As well as being a significant indicator 
of the perceived quality of care and success of health care 
services in general,8,9 past research has demonstrated patient 
satisfaction to be a key determinant of adherence to medical 
advice.10 Logically, if patients are satisfied with a service 
such as the MUR, this has the potential to improve their 
adherence, and measuring patient satisfaction, for example 
using a questionnaire, could then become a valid mechanism 
for auditing service quality.7,11 But existing pharmacy patient 
satisfaction questionnaires offer limited scope as detailed in 
the following paragraphs.
The hallmark of a good questionnaire is one that fully 
captures all of the constructs relating to the concept it is 
measuring.12 An in-depth review conducted by Panvelkar 
et al13 evaluated five instruments for measuring patient satis-
faction with community pharmacy services per se, none of 
which was developed by collaborating with patients to obtain 
their perspectives on the topic. Moreover, only two of the 
instruments14,15 focused on patient satisfaction with services 
that might resemble the MUR, and while one requires further 
testing14 the other was developed in the Spanish language.15 
A different, more recently published study can also be 
criticized for not being based on patients’ own perspec-
tives of the pharmacy service in question.16 Examining the 
broader concept of pharmaceutical care services provided 
for outpatients, a more recent review of patient satisfaction 
questionnaires unearthed 12 studies, but highlighted that only 
one study had developed an instrument to be directly applied 
in the evaluation of community pharmacy services.17 The 
authors recommended that consistent with Donabedian’s 
framework,18 future research should be directed toward the 
development and validation of structure, process, and out-
come indicators for evaluating the quality of pharmaceutical 
care services. The constructs identified by patients as being 
important to their experience and satisfaction with the MUR 
have in fact been previously mapped against Donabedian’s 
structure–process–outcome framework.19 Based on the 
MUR patient satisfaction framework,19 the current paper 
aimed to assess patient satisfaction with the MUR service by 
developing, piloting, and utilizing a new MUR patient sat-
isfaction questionnaire (MUR-PSQ), which was completed 
and is described here.
Materials and methods
compliance with ethical standards
This study was approved by the University of Reading’s 
Research Ethics Committee through the School Exemptions 
process reference number 13/16 on 25/02/2016.
instrument development and content 
validation
The MUR-PSQ version 1 (v1) was designed to have items that 
were relevant to patient satisfaction with the MUR service19 
and be simple and easy to understand, with clear instructions, 
and a reasonable completion time (,10 minutes). There-
fore there were no negatively worded items or reverse scor-
ing of any item. The MUR-PSQ-v1 included 12 positively 
worded questions (items) each with a 5-point Likert response 
scale (1= strongly disagree to 5= strongly agree). A comments 
box was also added to check that the questionnaire captured 
all of the relevant concepts being expressed by people expe-
riencing the service.
Ascertaining the content validity index (CVI) was deemed 
appropriate for establishing the content validity (CV) of the 
questionnaire. This is because CVI measures the extent of 
agreement between experts about each questionnaire item 
(hereon referred to as the item CVI; I-CVI), and this helps 
improve each question where needed.20 A panel of 12 phar-
macists involved in patient care (eg, community or hospital 
pharmacy posts) was recruited for the CV exercise. Specifi-
cally, a set of three questions for validating each item of the 
MUR-PSQ-v1 (Table 1) was devised by adapting an estab-
lished cognitive theory model for determining CV.21 Each 
pharmacist panel member was asked to read each of the items 
on the MUR-PSQ-v1 in turn and answer three distinct CV 
questions on a 4-point Likert response scale from (1= strongly 
disagree to 4= strongly agree). The three distinct CV ques-
tions were “Q1. This question is easy to understand,” “Q2. 
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The responses available are appropriate for the question 
asked” and “Q3. This question is relevant to measuring 
patient satisfaction with an MUR service.”
The I-CVI was determined by calculating the proportion of 
panel members who gave a rating of 3 or 4 (agree or strongly 
agree) to each of three CV questions relating to each questionnaire 
item. An I-CVI of $0.83 (10 ratings of 3 or 4 from 12 ratings) was 
judged as the minimum acceptable value for the combined rating 
for responses to each CV question. This minimum acceptable 
value was based on Lynn’s criteria,22 and any item not receiving 
the minimum acceptable value for any of the three CV questions 
was subjected to revision and re-evaluation.
The response options were judged to be appropriate for 
all 12 items of the questionnaire (CV Q2 I-CVI $0.83), and 
all 12 items were judged to be relevant (CV Q3 I-CVI $0.83) 
for measuring patient satisfaction with MURs (Table 1). 
The panel recommended rephrasing three items (items 4, 5, 
and 12) for greater clarity (CV Q1). The wording of these 
was amended to produce a second version of the MUR-PSQ 
version 2. A further review by the panel deemed all three 
revised items to be acceptable (I-CVI $0.83).
In addition to the this, the appropriateness and under-
standability of the MUR-PSQ-v1 in the target population 
was examined with the help of three community pharmacists 
in the East of England, who handed out the MUR-PSQ-v1 
(and accompanying information letters and return envelopes) 
to 60 patients following an MUR consultation during 
February–April 2016. Patients in turn posted their self-
completed questionnaire to the University for the authors’ 
attention. The returned questionnaires (n=30) were completed 
in full, and no comments regarding the questionnaire layout 
or wording were reported.
instrument testing
The revised questionnaire (MUR-PSQ-v2) was distributed 
to 250 community pharmacies belonging to one pharmacy 
chain in England (covering the South East, Central, and West 
of England, but with branches also in the North of England) 
between June and October 2016. Each pharmacy involved 
in the study received 20 patient questionnaire packs for 
distribution. The questionnaire packs contained the MUR-
PSQ-v2, an accompanying information letter, two copies 
of a written informed consent form, and a return envelope 
(addressed to the University for the authors’ attention). Each 
pharmacy also received a letter inviting the pharmacist to 
take part by handing out one questionnaire pack to each 
patient following an MUR consultation. It was not possible 
to accurately determine the number of patient packs handed 
out, but an attempt was made to estimate this through a 
retrospective telephone survey completed with the 250 
pharmacies. This involved one of the coauthors (CP) 
telephoning each pharmacy branch to ask about the number of 
questionnaire packs given out/remaining from the batch of 20 
packs sent to them. Patients in turn posted their self-completed 
questionnaire and one copy of the signed written informed 
consent form to the authors, thus allowing an estimation 
of the response rate to be made by dividing the number of 
responses returned to the researchers by the total number of 
patient packs which pharmacists declared to have handed out.
On receipt, the questionnaire responses were analyzed 
using the Statistical Software for Social Sciences version 21 
(IBM Corp., Armonk, NY, USA). Exploratory factor analysis 
was carried out to identify, understand, and interpret the rela-
tionships between the items on the MUR-PSQ-v2, explicitly 
in order to determine independent latent constructs known as 
“factors.” As part of the analysis, the correlation between the 
variables was examined by creating a correlation matrix.
The Kaiser–Meyer–Olkin (KMO) value was used to eval-
uate sample adequacy for factor analysis, where a KMO of 0.5 
is considered to be minimum, 0.5–0.7 mediocre, 0.7–0.8 good, 
0.8–0.9 great, and .0.9 superb.23 Bartlett’s test of sphericity 
was also completed to ensure that the study assumptions 
were satisfied for factor analysis by looking for a statistically 
significant value of less than 0.05.23
Table 1 Panel response for i-cVi of the MUr-PsQ-v1
MUR-PSQ-
v1 item
Content 
validity Q1 
Understanding 
of question
I-CVI
Content 
validity Q2 
Appropriateness 
of responses
I-CVI
Content 
validity Q3 
Relevance 
of questions
I-CVI
1 0.83 1.0 0.83
2 1.0 1.0 0.83
3 0.92 1.0 1.0
4 0.67a 0.92 0.92
5 0.58a 1.0 1.0
6 1.0 1.0 1.0
7 0.83 0.92 0.92
8 1.0 1.0 1.0
9 0.83 1.0 1.0
10 1.0 0.92 1.0
11 1.0 0.92 1.0
12 0.75a 0.92 0.92
Notes: For each item, a question asked to experts to answer “Q1. This question 
is easy to understand”; also “Q2. The responses available are appropriate for the 
question asked”; and “Q3. This question is relevant to measuring patient satisfaction 
with an MUr service” on a 4-point likert response scale from (1= strongly disagree 
to 4= strongly agree). The i-cVi was determined by calculating the proportion of 
panel members who gave a rating of 3 or 4 (agree/strongly agree) to each of the three 
cV questions. aDid not at first meet minimum acceptable value for I-CVI (,0.83).
Abbreviations: i-cVi, item-level content validity; MUr-PsQ-v1, Medicines Use 
review patient satisfaction questionnaire, version 1.
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A number of procedures exist to determine the optimal 
number of factors to retain in exploratory factor analysis. 
In this study, based on Kaiser’s criteria,23 factors with eigen-
values greater than 1 were selected. Also, the scree plot 
method,23 a subjective test requiring researchers’ judgment, 
was used to confirm factor findings. Construct validity was 
confirmed if the factors accounted for a minimum of 50% 
of the variance.24 Items on the questionnaire were grouped 
into factors based on the factor loadings, and an item was 
considered significant if its loading was $0.40.25 To retain 
an item, the factor loading of the item was higher than 0.30. 
Cronbach’s α was used to measure the instrument’s inter-
nal reliability by evaluating the consistency of responses 
between the items contained within any identified factors 
on the MUR-PSQ-v2.26
The MUR-PSQ-v2 survey responses were also examined 
for patient-reported satisfaction with MURs. In addition, the 
handwritten comments received were analyzed by theoretical 
thematic analysis,27 meaning data were examined, coded, 
and themed for ideas that related to the research question, 
ie, patients’ satisfaction with MURs. The themes generated 
were juxtaposed against items on the MUR-PSQ-V2 to check 
if the questionnaire captured all of these concepts.
Results
All 250 branches of a community pharmacy chain (covering 
mainly the South East, Central, and West of England, but with 
branches also in the North of England) were invited to take 
part by handing out one questionnaire pack to each patient 
following an MUR consultation. A telephone survey com-
pleted between November and December 2016 estimated that 
2,151 questionnaires had been given out to patients. A total 
of 505 questionnaires were returned by patients to the authors, 
resulting in an estimated response rate of 24%.
exploratory factor analysis & reliability 
testing
The intercorrelation between all the items was 0.2–0.825, 
which provided an indication that all the individual items 
were interrelated yet not redundant or highly correlated 
(Table S1).23 A high KMO value of 0.94 confirmed that the 
sample was acceptable for factor analysis.23 Additionally, 
Bartlett’s test of sphericity (4,229.155, df=66, p=0.000) 
confirmed that the assumptions for factor analysis were sat-
isfied in this study. Based on the Kaisers criteria, in which 
factors with eigenvalue .1 are retained (Table S2), factor 
analysis presented two factors, with a cumulative variance 
of 68.8%. The presence of two factors was also confirmed 
with the scree plot.
None of the items loaded significantly onto both fac-
tors, thereby indicating the uniqueness of each individual 
item and its specificity to a certain factor (Table 2). The 
first factor had 7 items and was labeled as “experiencing 
the service”, while the other 5 items loaded onto factor 2 
which was labeled as “judging the service.” Furthermore, 
reliability analysis using Cronbach’s α revealed that all items 
on factor 1 (α=0.90) and factor 2 (α=0.89) had excellent 
internal consistency.
Patient satisfaction with the MUr
A total of 489 people (97%) agreed or strongly agreed that 
they were satisfied with the MUR service they had received 
(Table S3, specifically responses to item 12). Agreement was 
highest in relation to satisfaction with the time spent by the 
pharmacist listening (98%) and the pharmacist’s personal 
approach toward the patient (98%). There was also high sat-
isfaction with explanations of the aims of the service (96%), 
Table 2 MUr-PsQ-v2 items and their loadings on the two 
extracted factors
Survey item Factor 1 Factor 2
 1. I am satisfied with the pharmacist’s 
explanation of the aims of the MUr 
service to me
0.50 0.22
 2. I am satisfied with the privacy and 
comfort of the consultation room
0.45 0.15
 3. I am satisfied with the time the 
pharmacist spent listening to me
0.87 -0.27
 4. I am satisfied with the pharmacist’s 
personal approach towards me
0.91 -0.13
 5. I am satisfied with the opportunity 
i had to raise questions or concerns
0.85 -0.51
 6. I am satisfied with the pharmacist’s 
advice and recommendations
0.68 0.18
 7. i wanted to have an MUr consultation -0.11 0.74
 8. The pharmacist answered my 
questions or concerns
0.54 0.31
 9. I now feel more confident about 
managing my condition
0.09 0.75
 10. i would use the MUr service again 
in the future
-0.02 0.91
 11. i would recommend the MUr service 
to others
0.05 0.84
 12. I was satisfied with the MUR service 
i took part in
0.36 0.55
Notes: Factor 1 was labeled “experiencing the service”, while Factor 2 was labeled 
“Judging the service”. extraction method: Principle axis factoring, rotation method: 
Promax. Significant factor loadings are shown in bold (.0.40).
Abbreviation: MUr-PsQ-v2, Medicines Use review patient satisfaction ques-
tionnaire, version 2.
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the comfort and privacy of the consultation room (96%), the 
opportunity to raise questions or concerns (97%) and have 
these answered (95%), and generally the pharmacists’ advice 
and recommendations (96%). Eight out of ten patients agreed 
they felt more confident about their condition following the 
MUR. Interestingly, only 328 people (65%) had wanted 
to have an MUR at the outset. Despite this, nine out of ten 
people would use the service again, and the same number 
would recommend it to others.
The handwritten comments on the returned question-
naires were grouped into four main themes, which are 
shown below with illustrative quotes. The themes identified 
could all be mapped against the items on the MUR-PSQ-v2 
(Table 3).
Theme 1: Perceptions about the MUr service itself
Positive perceptions
This subtheme relates to positive perceptions about the MUR, 
such as it being a helpful, reassuring, informative, and per-
sonalized patient–pharmacist discussion. For example:
Found it very helpful to have this MUR with my local 
pharmacist if anything more helpful than my GP. (Patient 
no 217)
Didn’t realize just how beneficial this service could be 
to me – felt more comfortable, reassured, realized more 
could be done for me as when necessary – very good. 
(Patient no 218)
negative perceptions
This subtheme relates to negative perceptions about the 
MUR, mainly about the purpose of the MUR being unclear. 
For example:
Think this is a waste of time and money. If I need further 
advice I would ask my doctor and consultant has already 
explained the medications. (Patient no 299)
Theme 2: Pharmacist’s delivery of the MUR service
Pharmacist mannerism
This subtheme relates to pharmacists being professional, 
approachable, helpful, friendly, or caring. For example:
The pharmacist was very friendly and made me feel very 
well calm and comfortable. (Patient no 364)
The pharmacist was very helpful young man, and did 
not try to rush me through it. (Patient no 211)
Pharmacist communication style
This subtheme relates to pharmacists as people who offered 
advice, answered relevant questions, and delivered ade-
quate as well as new explanations about medications. For 
example:
My pharmacist advised me on questions I had and also 
taught me some things I did not know. (Patient no 93)
I am grateful to be given the chance and time to ask 
questions about the medications I take and their interaction 
with each other. The pharmacist also suggested the best 
times to take individual drugs. (Patient no 310)
Theme 3: The consultation room setting
This theme relates to the privacy and size of the consultation 
room. For example:
The only issue I had was once in consulting room anybody 
on other side of the room could hear! (Patient no 155)
Table 3 The themes and subthemes generated from analyzing 
comments made on returned questionnaires
Theme Subtheme MUR-PSQ-v2 item
Perceptions 
about the MUr 
service itself
Positive 
perceptions
Q9: I now feel more confident 
about managing my condition
Q10: i would use the MUr service 
again in the future
Q11: i would recommend the 
MUr service to others
negative 
perceptions
Q12: I was satisfied with the 
MUr service i took part in 
(ie, respondents could disagree)
Pharmacist’s 
delivery of the 
MUr service
Pharmacist 
mannerism
Q3: I am satisfied with the time the 
pharmacist spent listening to me
Q4: I am satisfied with the 
pharmacist’s personal approach 
towards me
Q5: I am satisfied with the 
opportunity i had to raise 
questions or concerns
Pharmacist 
communication 
style
Q1: I am satisfied with the 
pharmacist’s explanation of the 
aims of the MUr service to me
Q6: I am satisfied with the 
pharmacist’s advice and 
recommendations
Q8: The pharmacist answered my 
questions or concerns
The consultation 
room setting
n/A Q2: I am satisfied with the privacy 
and comfort of the consultation 
room
lack of 
awareness of the 
service before 
having an MUr
n/A Q7: i wanted to have an MUr 
consultation
Note: The themes and subthemes were mapped against the MUr-PsQ-v2 items to 
check the continued relevance of the questionnaire against participants’ additional 
notes.
Abbreviations: MUr-PsQ-v2, Medicines Use review patient satisfaction ques-
tionnaire, version 2; n/A, not applicable.
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Consultation room was very small referred to as cup-
board, but ok. (Patient no 240)
Theme 4: lack of awareness of the service before 
having an MUr
This theme relates to people being unaware of the MUR 
service prior to their consultation. For example:
I was unaware of this service. Anything which assists a per-
son to feel supported/have the opportunity to further discuss 
medications is very much appreciated. (Patient no 230)
I was unaware of the MUR until invited to discuss my 
medication with the pharmacist. (Patient no 30)
Discussion
A new questionnaire was devised, piloted, and tested for the 
purpose of measuring patient satisfaction with the MUR ser-
vice in the UK. The CVI and piloting established the clarity, 
relevance, and appropriateness of all 12 items on the MUR-
PSQ-v2. Exploratory factor analysis extracted two unique 
factors labeled as “experiencing the service” and “judging 
the service” without dual loadings. Moreover, Cronbach’s α 
revealed high internal consistency between the items grouped 
under each of the two factors. The results of the survey infer 
a high degree of patient satisfaction with experiencing the 
MUR service as well as with judging its impact although this 
result is not conclusive considering the low response rate, 
which was estimated to be 24%.
The two factors identified through factor analysis, “expe-
riencing the service” and “judging the service”, concurred 
with the layout of the MUR-PSQ-v2, in which the first half 
focuses on the patient experience with the consultation while 
the second half focuses on the outcomes and evaluations 
of the MUR service itself. These two factors bear some 
important similarities and differences with factors identi-
fied in previous patient satisfaction questionnaires. Previous 
questionnaires examining patient satisfaction with pharmacy 
services have generated multiple factors that are arguably 
irrelevant to the MUR adherence-focused service, including 
factors such as “financial aspects,” “product availability”, 
and “technical quality.”15,28,29 While the updated MacKeigan 
and Larson tool14 produced two dimensions that share some 
commonality with the “experiencing the service” factor, the 
MUR-PSQ-v2 factor “judging the service” is new, perhaps 
because the current questionnaire is rooted in patients’ 
perspectives, which is detailed elsewhere.19 In comparison 
to previous instruments,14–16,28–30 limiting the questionnaire 
to 12 specific items also avoided drawbacks commonly 
identified in previous surveys such as lengthy completion 
time and multiple dual loadings.
When analyzing people’s responses on the MUR-
PSQ-v2, a high degree of satisfaction with the MUR service 
was found, which as stated earlier, needs to be treated with 
caution in light of the low response rate. This is in line with 
two previous formal studies that have shown high patient 
satisfaction with community pharmacy services16,30 and with 
one study that more informally examined patient satisfaction 
with the MUR service.31 Of particular interest was item 7, 
“I wanted to have an MUR consultation’, which produced a 
considerably lower score than all the other items – ie, 33% 
of the respondents did not agree/strongly agree with this 
statement. Despite this response, patients who received the 
MUR service and returned the questionnaire were very satis-
fied with it. Similarly, previous qualitative studies showed 
that patients who take part in MURs did not necessarily 
want the service at first or think they will benefit from it.19,32 
This is in line with a general reluctance to use community 
pharmacy services, as reported elsewhere.33–35 However, 
what is important about the current study is that it has shown 
that reluctance to take part does not equate with satisfaction 
once the service is experienced. Therefore, it can be argued 
that focusing on patient recruitment processes, eg, whether 
reluctant patients are being recruited, is not a valid measure 
of patient satisfaction with the MUR service.
To our knowledge, this is the first quantitative, national 
study of patient satisfaction with the MUR service carried 
out in the UK. In addition, this is one of only a handful of 
“pharmacy adherence service” patient satisfaction question-
naires developed on the basis of patients’ perspectives. This 
case is being made because, as demonstrated in the “Introduc-
tion” section, a highly relevant in-depth review by Panvelkar 
et al13 unearthed only five relevant instruments, and our own 
search found one more research questionnaire,16 none of which 
was developed through patient collaboration. And although 
the MUR-PSQ-v2 was not developed actively with patients, it 
was nonetheless based on patient perspectives and organized 
into a framework of MUR satisfaction as illustrated in a previ-
ously published paper.19 Another strength of the current study 
is that the MUR-PSQ-v2 underwent thorough testing before, 
during, and after development to enhance its trustworthiness. 
With only 12 items included in the questionnaire, the instru-
ment can be deemed to be easy to use and also to compute for 
the purpose of analysis. The study provides a mechanism for 
measuring people’s satisfaction with the MUR service. This 
could be useful for auditing, comparing, and improving this 
pharmacy adherence service. In addition, since medication 
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adherence reviews are offered as a pharmacy service across 
a number of European countries,6 the MUR-PSQ-v2 provides 
a basis for adaptation and use in Europe and beyond.
A limitation of the study is the apparent low response rate 
for the survey, which was calculated by dividing the number 
of responses returned to the researchers by the total number 
of patient packs which pharmacists declared to have handed 
out, the latter determined during a retrospective telephone 
survey. The potential for an “over statement” bias cannot be 
ruled out, with pharmacists overstating the number of patient 
packs they distributed to patients in order to demonstrate 
better engagement with the project, which would superficially 
inflate the denominator and result in a lower response rate. 
On the face of it, the current response rate means that it is 
possible the survey did not capture responses from a large 
proportion of questionnaire recipients, either because they 
were unable to complete the questionnaire or were not satis-
fied with their MUR and did not want to report this. 
Having said that, looking at recent literature in this field, 
the response rate is similar to another satisfaction study in phar-
macy that also relied on the postal service36 (19.2% response 
rate), which is important considering that studies which rely 
on handing out and being handed back questionnaires within 
the pharmacy setting still do not result in sizeable response 
rates (45.85%37 and 58%38). The decision to ask patients to 
post their questionnaires directly back to the researchers was 
made to reduce the chances of introducing unwanted bias. For 
example, posting the completed questionnaires directly to the 
research team meant that individual pharmacists delivering the 
service were bypassed, thereby eliminating the risk of phar-
macists concealing less favorable returned responses from the 
research team, and the process was also thought to encourage 
honest patient responses by affording anonymity. 
There is of course the possibility of selection bias in 
terms of whom the pharmacists chose to receive the MUR 
patient packs, which could only be addressed through more 
labor-intensive, less cost-effective methodologies relying on 
independent researchers handing out and collecting back the 
satisfaction questionnaires, which was outside of the scope of 
this study. However, by virtue of the questionnaire’s design, 
it was important that patients completed the MUR-PSQ-v2 
away from the pharmacy, having had the opportunity to 
reflect on their experience in order to answer the questions 
associated with factor 2, “judging the service”.
Conclusion
This study has produced the MUR-PSQ-v2 as a tool to 
measure patient satisfaction with the adherence-focused 
MUR service. This is the first MUR-PSQ based on a frame-
work built on patients’ perspectives. Survey scores revealed 
that patients who completed and returned the survey were 
satisfied with their MUR service despite initial reluctance to 
participate. The development of the MUR-PSQ-v2 is a sig-
nificant advancement for evaluating patient satisfaction with 
community pharmacy adherence services such as the MUR. 
Future research will confirm the findings of this study with a 
wider population of patients, and the questionnaire could be 
used for auditing, comparing, and improving the MUR and 
other adherence services in the UK and beyond.
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 1. Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. 
Geneva: World Health Organization; 2003.
 2. Holloway K, van Dijk L. The World Medicines Situation 2011: Rational 
Use of Medicines. Geneva: World Health organization; 2011.
 3. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 
2005;353:487–497.
 4. Simpson S, Eurich D, Majumdar S, et al. A meta-analysis of the 
association between adherence to drug therapy and mortality. BMJ. 
2006;333:15.
 5. Bulajeva A, Labberton L, Leikola S, et al. Medication review practices 
in European countries. Res Social Adm Pharm. 2014;10:731–740.
 6. The Prescribing Services Negotiating Committee. Medicines Use Review 
(MUR). Available from: http://psnc.org.uk/services-commissioning/
advanced-services/murs/. Accessed March 7, 2017.
 7. Murray C, Frenk J. A framework for assessing the performance of 
health systems. Bull World Health Organ. 2000;78:171–731.
 8. Aharony L, Strasser S. Patient satisfaction: What we know about and 
what we still need to explore. Med Care Res Rev. 1993;50:49–79.
 9. Clearly P, McNeil B. Patient satisfaction as an indicator of quality care. 
Inquiry. 1988;25:25–36.
 10. Ley P. Improving patients’ understanding, recall, satisfaction and com-
pliance. In: Broome K, editors. Health psychology. London: Chapman 
and Hall; 1989:74–102.
 11. Jackson J, Chamberlin J, Kroenke K. Predictors of patient satisfaction. 
Soc Sci Med. 2001;52:609–620.
 12. Marshall G, Hays R, Sherbourne C, et al. The structure of patient satisfaction 
with outpatient medical care. Psychol Assess. 1993;5:477–483.
 
Pa
tie
nt
 P
re
fe
re
nc
e 
an
d 
Ad
he
re
nc
e 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
4.
22
5.
10
9.
63
 o
n 
14
-N
ov
-2
01
7
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Patient Preference and Adherence 2017:11submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1804
hindi et al
 13. Panvelkar PN, Saini B, Armour C. Measurement of patient satisfac-
tion with community pharmacy services: a review. Pharm World Sci. 
2009;31:525–537.
 14. Larson L, Rovers J, MacKeigan L. Patient satisfaction with pharma-
ceutical care: update of a validated instrument. J Am Pharm Assoc. 
2002;42:44–50.
 15. Traverso M, Salamano M, Botta C, et al. Questionnaire to assess patient 
satisfaction with pharmaceutical care in Spanish language. Int J Qual 
Health Care. 2007;19:217–224.
 16. Sakharkar P, Bounthavong M, Hirsch J, et al. Development and vali-
dation of PSPSQ 2.0 measuring patient satisfaction with pharmacist 
services. Res Social Adm Pharm. 2015;11:487–498.
 17. Lima TM, Aguiar PM, Storpirtis S. Evaluation of quality indicator 
instruments for pharmaceutical care services: A systematic review 
and psychometric properties analysis. Res Soc Adm Pharm. Available 
from: http://linkinghub.elsevier.com/retrieve/pii/S1551741117300475. 
Accessed September 8, 2017.
 18. Donabedian A. Evaluating the quality of medical care. Milbank Q. 2005; 
83(4):691–729.
 19. van den Berg M, Donyai P. A conceptual framework of patient satis-
faction with a pharmacy adherence service. Int J Clin Pharm. 2014; 
36:182–191.
 20. Polit DF, Beck CT. The content validity index: are you sure you know 
what’s being reported? Critique and recommendations. Res Nurs Health. 
2006;29:489–497.
 21. Tourangeau R. Cognitive science and survey methods: A cognitive 
perspective. In: Jabine T, Straf M, Tanur J, et al, editors. Cognitive 
Aspects of Survey Methodology. Washington, DC: National Academy 
Press; 1984:73–100.
 22. Lynn M. Determination and quantification of content validity. Nurs 
Res. 1986;35:382–385.
 23. Field A. Discovering Statistics using SPSS. London: Sage Publications; 
2005.
 24. Terwee CB. Protocol for systematic reviews of measurement properties. 
Knowledge Center Measurement Instruments. 2011:13. Available from: 
http://www.cosmin.nl/images/upload/files/Protocol klinimetrische 
review version nov 2011.pdf
 25. Fabrigar L, Wegener D, MacCallum R, et al. Evaluating the use of 
exploratory factor analysis in psychological research. Psychol Methods. 
1999;4:272–299.
 26. Streiner D, Norman G, Cairney J. Health Measurement Scales: A Prac-
tical Guide to their Development and Use. 5th ed. Oxford: Oxford 
University Press; 2014:159–196.
 27. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res 
Psychol. 2006;3(2):77–101.
 28. MacKeigan LD, Larson LN. Development and validation of an instru-
ment to measure patient satisfaction with pharmacy services. Med Care. 
1989;27(5):522–536.
 29. Hasan S, Sulieman H, Stewart K, et al. Assessing patient satisfaction 
with community pharmacy in the UAE using a newly-validated tool. 
Res Social Adm Pharm. 2013;9:841–850.
 30. Gourley G, Gourley D, Rigolosi E, et al. Development and validation of 
the pharmaceutical care satisfaction questionnaire. Am J Manag Care. 
2001;7:461–466.
 31. Youssef S, Hussain S, Upton D. Do patients perceive any benefit from 
medicines use reviews offered to them in community pharmacies? 
Pharm J. 2010;284(7589):165–166.
 32. Latif A, Boardman H, Pollock K. Understanding the patient perspective 
of the English community pharmacy Medicines Use Review (MUR). 
Res Social Adm Pharm. 2013;9:949–957.
 33. Gidman W, Cowley J. A qualitative exploration of opinions on the 
community pharmacists’ role amongst the general public in Scotland. 
Int J Pharm Pract. 2012;21:288–296.
 34. McMillan S, Kelly F, Sav A, et al. Consumer and carer views of 
Australian community pharmacy practice: awareness, experiences and 
expectations. J Pharm Health Serv Res. 2013;5:29–36.
 35. Wood K, Gibson F, Radley A, et al. Pharmaceutical care of older people: 
what do older people want from community pharmacy? Int J Pharm 
Pract. 2015;23:121–130.
 36. Moon J, Kolar C, Brummel A, Ekstrand M, Holtan H, Rehrauer D. 
Development and validation of a patient satisfaction survey for com-
prehensive medication management. J Manag Care Spec Pharm. 2016; 
22(1):81–86.
 37. Alomi YA, Kurdy L, Aljarad Z, Basudan H, Almekwar B, Almahmood S. 
Patient satisfaction of pharmaceutical care of primary care centers at 
Ministry of Health in Saudi Arabia. J Pharm Pract Community Med. 
2016;2(23):79–87.
 38. Malewski DF, Ream A, Gaither CA. Patient satisfaction with com-
munity pharmacy: Comparing urban and suburban chain-pharmacy 
populations. Res Soc Adm Pharm. 2015;11(1):121–128.
 
Pa
tie
nt
 P
re
fe
re
nc
e 
an
d 
Ad
he
re
nc
e 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
4.
22
5.
10
9.
63
 o
n 
14
-N
ov
-2
01
7
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Patient Preference and Adherence 2017:11 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1805
MUr patient satisfaction questionnaire
Supplementary materials
Table S1 The correlation between MUr-PsQ-v2 items
Item no 1 2 3 4 5 6 7 8 9 10 11 12
1 1.00 0.433 0.588 0.530 0.530 0.547 0.418 0.497 0.500 0.524 0.512 0.582
2 0.433 1.00 0.526 0.458 0.429 0.399 0.299 0.402 0.453 0.410 0.430 0.470
3 0.588 0.526 1.00 0.714 0.658 0.655 0.346 0.617 0.535 0.572 0.565 0.652
4 0.530 0.458 0.714 1.00 0.634 0.642 0.298 0.606 0.457 0.502 0.521 0.599
5 0.530 0.429 0.658 0.634 1.00 0.716 0.341 0.684 0.507 0.492 0.548 0.602
6 0.547 0.399 0.655 0.642 0.716 1.00 0.425 0.685 0.576 0.611 0.625 0.677
7 0.418 0.299 0.346 0.298 0.341 0.425 1.00 0.463 0.567 0.555 0.574 0.468
8 0.497 0.402 0.617 0.606 0.684 0.685 0.463 1.00 0.647 0.624 0.609 0.669
9 0.500 0.453 0.535 0.457 0.507 0.576 0.567 0.647 1.00 0.715 0.670 0.680
10 0.524 0.410 0.572 0.502 0.492 0.611 0.555 0.624 0.715 1.00 0.825 0.757
11 0.512 0.430 0.565 0.521 0.548 0.625 0.574 0.609 0.670 0.825 1.00 0.756
12 0.582 0.470 0.652 0.599 0.602 0.677 0.468 0.669 0.680 0.757 0.756 1.00
Notes: The correlation between the variables was examined by creating a correlation matrix. Because the MUr-PsQ-v2 was constructed to measure one concept (patient 
satisfaction with an MUr), there is an expectation that the variables will correlate with each other. however, any variable with a consistently low correlation (less than 0.2) 
with other variables is potentially redundant. equally, a variable with a consistently high correlation (over 0.8) would cause multilinearity problems during factor analysis and 
might also need removing.
Abbreviation: MUr-PsQ-v2, Medicines Use review patient satisfaction questionnaire, version 2.
Table S2 Total variance and factors extracted
Factor Initial eigenvalues Extraction sums of squared loadings
Total % of variance Cumulative % Total % of variance Cumulative %
1a 7.170 59.749 59.749 6.827 56.892 56.892
2a 1.080 8.999 68.747 0.726 6.052 62.943
3 0.723 6.021 74.768
4 0.554 4.616 79.385
5 0.511 4.256 83.640
6 0.408 3.403 87.043
7 0.358 2.982 90.025
8 0.284 2.368 92.393
9 0.276 2.296 94.689
10 0.252 2.099 96.788
11 0.228 1.897 98.685
12 0.158 1.315 100.000
Notes: The eigenvalues for the correlation matrix were determined and are shown. Bold figures indicate that there are two factors that have an eigenvalues that are greater 
than 1. The cumulative % of variance for these two factors is 68.8%. Therefore, the two factors were included in the model. extraction method: Principal axis factoring. 
aFactors satisfied Kaisers criteria (eigenvalue .1).
Table S3 Respondents’ scores on the MUR-PSQ-v2
Survey 
items
Strongly disagree 
n (%)
Disagree
n (%)
Neither 
n (%)
Agree 
n (%)
Strongly agree 
n (%)
Missing
n (%)
1 1 (0.2) 4 (0.8) 17 (3.4) 197 (39) 285 (56) 1 (0.2)
2 0 (0) 7 (1.4) 15 (3.0) 180 (36) 303 (60) 0 (0)
3 1 (0.2) 2 (0.4) 6 (1.2) 152 (30) 344 (68) 0 (0)
4 0 (0) 0 (0) 9 (1.8) 109 (22) 387 (77) 0 (0)
5 0 (0) 2 (0.4) 12 (2.4) 154 (31) 336 (67) 1 (0.2)
6 0 (0) 2 (0.4) 18 (3.6) 142 (28) 342 (68) 1 (0.2)
7 5 (1.0) 15 (3) 147 (29) 161 (32) 167 (33) 10 (2)
8 0 (0) 2 (0.4) 20 (4.0) 167 (33) 311 (62) 5 (1)
9 1 (0.2) 5 (1.0) 85 (17) 163 (32) 249 (49) 2 (0.4)
10 2 (0.4) 6 (1.2) 33 (7) 177 (35) 284 (56) 3 (0.6)
11 2 (0.4) 4 (0.8) 39 (8) 168 (33) 292 (58) 0 (0)
12 2 (0.4) 1 (0.2) 13 (3) 170 (34) 319 (63) 0 (0)
Notes: The survey responses were collated and are shown as the number (and percentage) of responses on the 5-point likert scale for each item on the MUr-PsQ-v2. 
For example, 34% and 63% of 505 people responded “agree” or “strongly agree,” respectively, in relation to item 12.
Abbreviation: MUr-PsQ-v2, Medicines Use review patient satisfaction questionnaire, version 2.
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